RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction
Related Experiment Video
Updated: Dec 10, 2025

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
Published on: December 20, 2019
Mauro Montalbano1,2, Salome McAllen1,2, Nicha Puangmalai1,2
1Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Abstract:
Oligomeric assemblies of tau and the RNA-binding proteins (RBPs) Musashi (MSI) are reported in Alzheimer's disease (AD). However, the role of MSI and tau interaction in their aggregation process and its effects are nor clearly known in neurodegenerative diseases. Here, we investigated the expression and cellular localization of MSI1 and MSI2 in the brains tissues of Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) as well as in the wild-type mice and tau knock-out and P301L tau mouse models. We observed that formation of pathologically relevant protein inclusions was driven by the aberrant interactions between MSI and tau in the nuclei associated with age-dependent extracellular depositions of tau/MSI complexes. Furthermore, tau and MSI interactions induced impairment of nuclear/cytoplasm transport, chromatin remodeling and nuclear lamina formation. Our findings provide mechanistic insight for pathological accumulation of MSI/tau aggregates providing a potential basis for therapeutic interventions in neurodegenerative proteinopathies.
Insights
Aberrant interactions between Musashi (MSI) and tau proteins drive pathological inclusions in neurodegenerative diseases like Alzheimer's. This MSI-tau aggregation impairs cellular transport and chromatin, offering therapeutic targets.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Oligomeric assemblies of tau and RNA-binding proteins (RBPs), specifically Musashi (MSI), are implicated in Alzheimer's disease (AD).
- The precise role of MSI and tau interaction in their aggregation and its consequences in neurodegenerative diseases remain unclear.
Purpose of the Study:
- To investigate the expression and cellular localization of MSI1 and MSI2 in brain tissues from AD, ALS, and FTD patients.
- To examine the interaction between MSI and tau in various mouse models, including wild-type, tau knock-out, and P301L tau models.
Main Methods:
- Immunohistochemistry and biochemical analyses of brain tissues from human patients and mouse models.
- Assessment of protein localization, complex formation, and cellular transport mechanisms.
Main Results:
- Aberrant interactions between MSI and tau in the nucleus drive the formation of pathologically relevant protein inclusions.
- Age-dependent extracellular deposition of tau/MSI complexes was observed.
- Tau and MSI interactions led to impaired nuclear-cytoplasmic transport, chromatin remodeling, and nuclear lamina formation.
Conclusions:
- MSI-tau interactions are mechanistically linked to the pathological accumulation of aggregates in neurodegenerative proteinopathies.
- These findings provide a potential basis for developing therapeutic interventions targeting MSI/tau aggregates.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Regulation of Nuclear Protein Sorting
Nuclear Export of mRNA
Nuclear Localization Signals and Import
Bacterial Protein Maturation

